Resona Asset Management Co. Ltd. grew its holdings in Axon Enterprise, Inc (NASDAQ:AXON – Free Report) by 11.7% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 136,615 shares of the biotechnology company’s stock after acquiring an additional 14,257 shares during the quarter. Resona Asset Management Co. Ltd.’s holdings in Axon Enterprise were worth $57,618,000 at the end of the most recent reporting period.
Other large investors have also modified their holdings of the company. Creative Financial Designs Inc. ADV purchased a new position in shares of Axon Enterprise in the 4th quarter valued at approximately $28,000. Sound Income Strategies LLC grew its position in Axon Enterprise by 550.0% during the 4th quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company’s stock worth $30,000 after purchasing an additional 44 shares during the last quarter. Camelot Portfolios LLC purchased a new stake in Axon Enterprise during the 4th quarter worth approximately $30,000. AlphaCentric Advisors LLC acquired a new position in Axon Enterprise during the 4th quarter valued at approximately $34,000. Finally, Lodestone Wealth Management LLC acquired a new position in Axon Enterprise during the 4th quarter valued at approximately $35,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.
More Axon Enterprise News
Here are the key news stories impacting Axon Enterprise this week:
- Positive Sentiment: Axon is benefiting from renewed investor attention around major public-safety contract opportunities, including reported momentum tied to Immigration and Customs Enforcement and a larger Axon-aligned contract, which has helped reinforce the company’s growth narrative. Why Axon Enterprise (AXON) Is Up 14.2% After Trump Stake And New ICE Contract Momentum
- Positive Sentiment: Strong operating results continue to support the stock, with Axon recently posting record quarterly revenue of $807 million and beating EPS expectations, suggesting demand for its public safety technology remains robust. Axon Enterprise (AXON) Following Its Public Safety Platform Narrative Looks Fully Valued
- Positive Sentiment: Analyst commentary is still constructive, with Needham raising its price target to $750 and arguing Axon’s premium valuation is justified by durable booking growth. Needham Bets Axon’s Premium Is Sustainable at $750
- Neutral Sentiment: Some coverage highlights that Axon may already be fully valued after its sharp run-up, which could cap near-term upside even if the long-term story remains strong. Axon Enterprise (AXON) Following Its Public Safety Platform Narrative Looks Fully Valued
- Negative Sentiment: The stock has also faced some pushback from articles noting it underperformed peers and from local political controversy tied to Axon’s role in Scottsdale elections, which may weigh on sentiment. Axon Enterprise Inc. stock underperforms Wednesday when compared to competitors Conservatives challenge Axon’s role in Scottsdale elections
Axon Enterprise Stock Performance
Axon Enterprise (NASDAQ:AXON – Get Free Report) last released its quarterly earnings data on Wednesday, May 6th. The biotechnology company reported $1.61 EPS for the quarter, beating the consensus estimate of $1.60 by $0.01. The business had revenue of $807.35 million for the quarter, compared to the consensus estimate of $778.90 million. Axon Enterprise had a net margin of 6.90% and a return on equity of 3.78%. The business’s revenue for the quarter was up 33.7% on a year-over-year basis. During the same period in the prior year, the firm earned $1.47 EPS. On average, analysts anticipate that Axon Enterprise, Inc will post 1.63 EPS for the current year.
Analyst Ratings Changes
A number of research analysts have issued reports on the stock. Morgan Stanley set a $600.00 price objective on shares of Axon Enterprise in a research note on Thursday, May 7th. TD Cowen dropped their price objective on shares of Axon Enterprise from $950.00 to $825.00 and set a “buy” rating on the stock in a report on Wednesday, April 8th. Needham & Company LLC upped their target price on Axon Enterprise from $600.00 to $750.00 and gave the company a “buy” rating in a research report on Monday. Citizens Jmp restated a “market outperform” rating and issued a $700.00 target price on shares of Axon Enterprise in a research note on Thursday, June 25th. Finally, The Goldman Sachs Group set a $535.00 price target on Axon Enterprise in a research report on Thursday, May 7th. One analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $722.12.
Check Out Our Latest Stock Report on Axon Enterprise
Insider Activity at Axon Enterprise
In other Axon Enterprise news, insider Elizabeth Reid Coughlin sold 1,554 shares of the stock in a transaction dated Thursday, June 4th. The stock was sold at an average price of $485.00, for a total transaction of $753,690.00. Following the sale, the insider directly owned 34,024 shares of the company’s stock, valued at approximately $16,501,640. This trade represents a 4.37% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CRO Cameron Brooks sold 1,242 shares of Axon Enterprise stock in a transaction dated Thursday, June 4th. The shares were sold at an average price of $500.00, for a total value of $621,000.00. Following the transaction, the executive owned 49,710 shares of the company’s stock, valued at $24,855,000. The trade was a 2.44% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 48,989 shares of company stock valued at $24,090,083 over the last ninety days. Corporate insiders own 4.20% of the company’s stock.
Axon Enterprise Profile
Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.
Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.
Further Reading
- Five stocks we like better than Axon Enterprise
- A Market Panic Just Discounted the AI Highway’s Tollbooth
- Why Exxon Could Be the Market’s Next Big Comeback Stock
- The Market Just Got Shaken—These 3 ETFs May Come Out Stronger
- Meta Platforms’ Cloud Push: Growth Opportunity Versus AI Concerns
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.
